Prof. Mike Chan Returns to Baoding, Urges Global Action on Autism and Precursor Stem Cells Innovation

BAODING, CHINA, June 29, 2025 – World-renowned regenerative medicine pioneer Prof. Dr. Mike Chan delivered an impassioned keynote at a high-level international pediatric conference in Baoding today, urging global stakeholders to fast-track the translation of stem cell research into real-world treatments—especially for children with autism.

The conference, titled “The Innovative Applications and Translation of Stem Cell Therapy in Refractory Childhood Diseases,” brought together scientists, health officials, and foreign delegates to advance Sino-international cooperation in regenerative medicine, early childhood development, and healthcare industrialization.

Returning to Baoding just months after his groundbreaking March visit, Prof. Chan was welcomed as a central figure in China’s drive to position Baoding as a global hub for pediatric medical innovation.

Prof. Chan said during his address.

“Autism is not a mystery anymore. It is cellular. It is biomedical. It is environmental. And it is treatable—if we act early and decisively.”

A Vision Forged in March, Reinforced in June

Prof. Mike Chan’s return follows his March 10 mission, where he led the signing of three major cooperation agreements between the European Wellness Biomedical Group, Baoding Children’s Hospital, Hebei Sanzang Biotechnology, and Germany’s SenValis Group. That visit resulted in the formation of two joint laboratories: one focused on precursor stem cell therapy for Autism Spectrum Disorder (ASD), and the other on environmental influences on pediatric health.

Today’s summit marked a significant follow-up, with high-level officials from Hebei Province and Baoding Municipal Government reaffirming their commitment to global biomedical cooperation.

Among the guests were:

• Ma Yimin, Deputy Secretary of the Baoding High-Tech Zone Party Committee
• Feifei Zhao, Director of BWA China Government Affairs
• Claus W. Biermann, Chair of the BWA Global Health Expert Committee (online)
• Andreas Hube, CEO of SenValis Group (online)
• Alexander V. Dmitriev, Russian virologist and head of the advanced genetic research lab
• Deling Cao, Professor of Molecular Oncology, Southern Illinois University

“We Lose 95% of Our Stem Cells by Age 60. That’s the Clock We’re Racing Against.”

In his opening lecture, “Autism in Children and Stem Cell Therapy,” Prof. Chan shared findings from over four decades of clinical work with precursor stem cells, emphasizing the critical window of early intervention.

“You are born with 37.2 trillion life cells, and just one stem cell per 10,000,”he explained.“By 18, you’ve lost more than half. By 60, just 5% remain. When a child is diagnosed with autism, the clock starts ticking.”

“We’re not just injecting cells, we’re awakening repair systems. The body has the blueprint. Stem cells bring the tools.”

Prof. Chan linked environmental factors such as prenatal toxin exposure, gestational stress, infections, and inflammation to the sharp rise in ASD globally—echoing themes from scientific posters displayed throughout the venue, including one on “Brain Development & Maturation” showing how early environmental factors alter neurological outcomes.

A Convergence of Science, Government, and Industry

The full-day agenda featured top-tier international presentations on virology, genetic prediction, environmental health, liver disease, and bio-industrial transformation. It was hosted at the Baoding Zhongbo Hilton Yulin Hotel, with over 200 in-person attendees and livestreams reaching audiences across China, Germany, and Southeast Asia.

Prof. Mike Chan’s message resonated with fellow speakers, including:

• Claus W. Biermann, who outlined future Sino-German medical alliances
• Andreas Hube, who explored how pollution and allergens worsen pediatric asthma and autism
• Feifei Zhao, who presented on KTK (Klinik Test Kit) predictive tools in stem cell readiness
• Deling Cao, who discussed serum markers for early detection of liver carcinoma

“We are seeing a turning point where stem cell therapy is moving from bench to bedside,” Prof. Mike Chan declared. “What we’re building here in Baoding is not a lab—it’s a launchpad for global change.”

Building the Future in Baoding

The Baoding International Medical Hub is a flagship project under China’s national health decentralization plan. With support from President Xi Jinping, who visited the region in October 2023, Baoding is tasked with becoming a world-class research and treatment center. The construction of the International Precursor Stem Cell Therapy Joint Laboratory, expected to be operational by October 2025, is a cornerstone of this transformation.

“China is not just importing science,” Prof. Mike Chan emphasized. “China is now innovating, industrializing, and setting a gold standard for integrative pediatric medicine.”

A Global Call to Action

As the summit concluded, Prof. Chan met with key officials and academic partners to discuss the next phase: implementing clinical trials, fast-tracking regulatory pathways, and expanding public education on stem cell medicine.

“The science is ready. The technology is mature. The families are waiting,” he said. “What we need now is collective will, from governments, scientists, and investors—to bring this to every child who needs it.”

From Baoding to Berlin, from research papers to real patients, Prof. Mike Chan’s journey continues to challenge conventional timelines in medicine. With every speech, every lab built, and every child treated, his vision of regenerative healing draws one step closer to reality.